GlassScriptPhysician profile
Brian Michael Alva
NPI 1225488612
$1,446.40
in general payments reported to CMS, 2019-2025
18 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.84 · 2020: $43.59 · 2021: $267 · 2022: $318 · 2023: $278 · 2024: $290 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.53 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Kala Pharmaceuticals, INC. | $220.92 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $167.85 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $136.76 | 2022-2025 | Precision 1, Rocklatan, Total30 |
| Sun Pharmaceutical Industries INC. | $126.35 | 2021-2023 | Cequa |
| Coopervision INC. | $85.94 | 2025 | Clariti Contact Lens, Misight Contact Lens |
| Dompe US, INC. | $52.12 | 2021-2024 | Oxervate |
| Aerie Pharmaceuticals, INC. | $46.89 | 2021 | |
| Lombart Brothers, INC. | $41.40 | 2023-2024 | Opd-III |
| Horizon Therapeutics Plc | $36.46 | 2022 | |
| Bausch & Lomb Americas INC. | $36.05 | 2022-2024 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.03 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $24.03 | 2024 | Acthar |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.87 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $17.44 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Oyster Point Pharma, INC. | $17.37 | 2024 | Tyrvaya |
| Sight Sciences, INC. | $14.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Alva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.